Oxford Drug Design shortlisted for CogX 2020 award for ‘Best AI Product in Health’
Oxford Drug Design is proud to have been shortlisted for this year’s CogX award for ‘Best AI product in health’. CogX is […]
Meet ODD at these spring events
Unfortunately due to COVID-19 the events listed have been cancelled. We look forward to meeting you at future events. Oxford Drug Design […]
Oxford Drug Design wins UK-China AMR grant and boosts funding with investment from the Angel CoFund
Oxford University biotech spin-out receives over £2 million to take its drug discovery programme to the next level. Oxford Drug Design Limited […]
Oxford Drug Design presents at CDD 2019 Autumn Seminar Series
Oxford Drug Design recently attended an event at the Said Buisness School, in Oxford showcasing the latest developments of Collaborative Drug Discovery’s […]
Oxford Drug Design receives over £8m in grant and equity investment
Oxford Drug Design announced today success in securing funds, totalling over £8m, from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the UK […]
Dr Michael Charlton presents at CCG’s European User Group Meeting
Dr Michael Charlton recently presented our work in designing novel aminoacyl tRNA synthetase inhibitors at the Chemical Computing Group’s European User Group […]
Oxford Drug Design attends Fragments 2019
Marco Albanese recently presented a poster on using fragment-based approaches to discover compounds targeting the ATP-binding domain of bacterial histidine kinases at […]
Oxford Drug Design attends the 2nd SCI/RSC Symposium on Antimicrobial Drug Discovery
Prof. Paul Finn presented on a major cause of failure of antibacterial drug discovery projects, failure to accumulate sufficiently at the site […]
Oxford Drug Design attends the Theory and Modelling in Chemical Sciences Annual Symposium
Dr Paul Finn attended the theory and modelling chemical sciences annual symposium in Bristol. The theory and modelling in chemical sciences centre for doctoral […]
Oxford Drug Design attends the JPI-AMR workshop in Oxford
Oxford Drug Design attended the JPI-AMR workshop on “Getting small drug-like molecules into Gram-negative bacteria”. This workshop provided an excellent opportunity to […]
Oxford Drug Design attends CCG’s European User Group Meeting and Conference
Dr. Jerome Wicker recently presented our latest work on the effect of charge and conformation on enrichment of DUD-E targets. Using both […]
Dr. Pamela Brown FRSC joins the Oxford Drug Design Scientific Advisory Board
Oxford Drug Design is pleased to announce the appointment of Dr. Pamela Brown FRSC to the company’s Scientific Advisory Board. Dr. Brown […]